These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 14558293)
21. Atrial fibrillation: from ion channels to bedside treatment options. Singh B J Electrocardiol; 2009; 42(6):660-70. PubMed ID: 19520377 [TBL] [Abstract][Full Text] [Related]
22. [Mechanisms of action of antiarrhythmics in cardioversion of atrial fibrillation and atrial flutter]. Davy JM; Raczka F; Beck L; Piot C Arch Mal Coeur Vaiss; 2003 May; 96 Spec No 4():20-9. PubMed ID: 12852282 [TBL] [Abstract][Full Text] [Related]
23. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs. Shiroshita-Takeshita A; Sakabe M; Haugan K; Hennan JK; Nattel S Circulation; 2007 Jan; 115(3):310-8. PubMed ID: 17224477 [TBL] [Abstract][Full Text] [Related]
24. Mechanisms of action of class III agents and their clinical relevance. Dorian P Europace; 2000 Jul; 1 Suppl C():C6-9. PubMed ID: 11220521 [TBL] [Abstract][Full Text] [Related]
25. Is there a role for digoxin in atrial fibrillation without heart failure? Master J; Schweitzer P Cardiol J; 2009; 16(5):483-6. PubMed ID: 19753533 [TBL] [Abstract][Full Text] [Related]
26. New antiarrhythmic drugs for prevention of atrial fibrillation. Goldstein RN; Stambler BS Prog Cardiovasc Dis; 2005; 48(3):193-208. PubMed ID: 16271945 [TBL] [Abstract][Full Text] [Related]
27. Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics. Dobrev D; Nattel S J Cardiovasc Pharmacol; 2008 Oct; 52(4):293-9. PubMed ID: 18791467 [TBL] [Abstract][Full Text] [Related]
28. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart. Kumar K; Nearing BD; Carvas M; Nascimento BC; Acar M; Belardinelli L; Verrier RL J Cardiovasc Electrophysiol; 2009 Jul; 20(7):796-802. PubMed ID: 19298570 [TBL] [Abstract][Full Text] [Related]
29. [New antiarrhythmic drugs for therapy of atrial fibrillation: I. Ion channel blockers]. Ravens U; Wettwer E; Schotten U; Wessel R; Dobrev D Herzschrittmacherther Elektrophysiol; 2006 Jun; 17(2):64-72. PubMed ID: 16786464 [TBL] [Abstract][Full Text] [Related]
30. Drugs that interact with cardiac electro-mechanics: old and new targets for treatment. Kirchhof P; Fortmüller L; Waldeyer C; Breithardt G; Fabritz L Prog Biophys Mol Biol; 2008; 97(2-3):497-512. PubMed ID: 18406454 [TBL] [Abstract][Full Text] [Related]
31. When should we discontinue antiarrhythmic therapy for atrial fibrillation after coronary artery bypass grafting? A prospective randomized study. Izhar U; Ad N; Rudis E; Milgalter E; Korach A; Viola N; Levi E; Asraff G; Merin G; Elami A J Thorac Cardiovasc Surg; 2005 Feb; 129(2):401-6. PubMed ID: 15678052 [TBL] [Abstract][Full Text] [Related]
33. Is there a need for new antiarrhythmic drugs? Roden DM Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158 [TBL] [Abstract][Full Text] [Related]